Abstract: An electronic device may include: a first temperature sensor configured to measure a first temperature of a skin surface when a user comes into contact with a main body of the electronic device; a first heating element spaced apart from the first temperature sensor by a first predetermined distance; a second temperature sensor spaced apart from the first heating element by a second predetermined distance and configured to measure a second temperature inside the main body; and a processor configured to: estimate heat flux based on the first temperature and the second temperature; estimate a blood perfusion rate of the user based on a temperature of the first heating element and the first temperature, and estimate a core body temperature of a user based on the first temperature, the estimated heat flux, and the estimated blood perfusion rate.

Abstract: Provided is a glass product manufacturing apparatus. The glass product manufacturing apparatus includes a furnace including a gas heating zone and an electric heating zone, a first heat exchange module configured to recover heat from the furnace, and a pump configured to drive flow of a heat transfer medium fluid passing through the first heat exchange module, wherein at least a part of the first heat exchange module is thermally coupled with at least a part of an external surface of the electric heating zone. The glass product manufacturing apparatus may reduce defect rate while exhibiting high energy efficiency.

Abstract: A glass product manufacturing apparatus and a method of manufacturing glass products are disclosed. The glass product manufacturing apparatus includes a melting vessel, a support grating configured to support an outer wall of the melting vessel, a cooling module configured to cool the outer wall of the melting vessel, on the support grating, and a support frame detachably fastened to the support grating to limit a movement of the support grating. By using the glass product manufacturing apparatus and the method of manufacturing glass products, high energy efficiency is maintained even when operating, and a defect rate is reduced.

Abstract: A fusion protein comprising factor VII (FVII) and transferrin according to the present invention has an improved specific activity of FVII compared to existing FVII fusion proteins comprising other fusion partners than transferrin, and thus can be effectively used in a therapy using FVII.

Abstract: Provided is a glass product manufacturing apparatus. The glass product manufacturing apparatus includes a furnace including a gas heating zone and an electric heating zone, a first heat exchange module configured to recover heat from the furnace, and a pump configured to drive flow of a heat transfer medium fluid passing through the first heat exchange module, wherein at least a part of the first heat exchange module is thermally coupled with at least a part of an external surface of the electric heating zone. The glass product manufacturing apparatus may reduce defect rate while exhibiting high energy efficiency.

Abstract: The present invention provides a pharmaceutical composition with improved stability, comprising a fusion protein comprising Factor VII (FVII) and transferrin, as an active ingredient, wherein the transferrin is linked to the C-terminus of the FVII; and trehalose or glycine as a bulking agent. The composition can store FVII and a variant thereof stably at room temperature for a long period of time. Thus it can be used as a useful therapeutic agent for patients suffering from hemophilia or congenital FVII deficiency.

Abstract: A fusion protein comprising factor VII (FVII) and transferrin according to the present invention has an improved specific activity of FVII compared to existing FVII fusion proteins comprising other fusion partners than transferrin, and thus can be effectively used in a therapy using FVII.

Abstract: The present invention provides a pharmaceutical composition with improved stability, comprising a fusion protein comprising factor VII(FVII) and transferrin, as an active ingredient, wherein the transferrin is linked to the C-terminus of the FVII; and trehalose or glycine as a bulking agent. The composition can store FVII and a variant thereof stably at room temperature for a long period of time. Thus it can be used as a useful therapeutic agent for patients suffering from hemophilia or congenital FVII deficiency.

Abstract: A fusion protein comprising factor VII (FVII) and transferrin according to the present invention has an improved specific activity of FVII compared to existing FVII fusion proteins comprising other fusion partners than transferrin, and thus can be effectively used in a therapy using FVII.

Abstract: The present invention provides a method of isolating and purifying a fusion protein comprising factor VII, and more specifically relates to a method of isolating and purifying a fusion protein comprising factor VII and transferrin, to a high degree of purity. Because the present invention provides a method whereby a recombinant fusion protein comprising factor VII can be isolated and purified to a high degree of purity, the invention is useful in producing a pharmaceutical preparation comprising factor VII that can be used in situations in which copious bleeding occurs such as surgery.

Abstract: A branching device for enclosing a hybrid fan-out cable the hybrid fan-out cable comprising plural optical cables and power cables, the branching device includes: an enclosure having a first end, through which the hybrid fan-out cable is inserted, and a second end that is opened; and a gasket provided at the second end of the enclosure and having plural through-holes; and a cover thread-coupled to the second end of the enclosure to fasten the gasket to the second end of the enclosure in such a manner that the through-holes are exposed. In the enclosure, the hybrid fan-out cable is branched out into plural individual sub-part cable components, and each of the sub-part cable components is drawn out through one of the through-holes of the gasket to the outside. The gasket is formed from an elastic material which forms a tight seal between the inner peripheral surface of the enclosure and with the outer peripheral surface of each of the sub-part cable components to seal the other end of the enclosure.

Abstract: An optical electrical hybrid cable for transmitting an optical signal and an electrical signal simultaneously is provided. The optical electrical hybrid cable includes a fiber-optic cable disposed in the center of the optical electrical hybrid cable, and including a plurality of tubes each of which comprises a plurality of optical fibers operatively mounted in an inner space thereof, and a first binder disposed around the plurality of tubes, a plurality of power cables disposed around the fiber-optic cable, each of the power cables comprising a plurality of conducting wires, and a second binder disposed around the plurality of power cables.

Abstract: A fusion protein comprising factor VII (FVII) and transferrin according to the present invention has an improved specific activity of FVII compared to existing FVII fusion proteins comprising other fusion partners than transferrin, and thus can be effectively used in a therapy using FVII.

Abstract: An optical electrical hybrid cable for transmitting an optical signal and an electrical signal simultaneously is provided. The optical electrical hybrid cable includes a fiber-optic cable disposed in the center of the optical electrical hybrid cable, and including a plurality of tubes each of which comprises a plurality of optical fibers operatively mounted in an inner space thereof, and a first binder disposed around the plurality of tubes, a plurality of power cables disposed around the fiber-optic cable, each of the power cables comprising a plurality of conducting wires, and a second binder disposed around the plurality of power cables.

Abstract: The application discloses Factor VIII polypeptides comprising internal deletions of amino acids within the area of residues 741 to 1689, wherein the thrombin cleavage sites at about 741 and about 1689 are present, and a site at about 1648 is not present, as compared to human Factor VIII.

Abstract: Disclosed is an interior optical cable including a plurality of tight buffer optical fibers; a subsidiary tension member surrounding the outer circumferences of the optical fibers; and an outer coating layer surrounding the subsidiary tension member, wherein the tight buffer optical fibers has a predetermined lay ratio to the outer coating layer.

Abstract: Disclosed is a fiber optic cable, comprising a central strength member, disposed at the center of the cable, for providing tensile strength; a plurality of inner tight buffered cores disposed in a linear form around the central strength member; a plurality of outer tight buffered cores, twisted in a spiral or S-Z form, for enclosing the inner tight buffered cores; and a jacket, disposed on an outermost circumference of the cable, for protecting an interior of the cable from external environments.

Abstract: An optical fiber cable and a method of fabricating the same are disclosed. The optical fiber cable includes at least one optical fiber including a core, which is an optical signal transmission medium, a clad surrounding an outer peripheral surface of the core, and a coating layer surrounding an outer peripheral surface of the clad. The optical fiber cable also includes an external sheath including a first layer having a predetermined thickness and a second layer made of polymer material and formed at an outer peripheral surface of the first layer through an extruding process and a waterproof member accommodated between the external sheath and the optical fibers. A plurality of recesses having a predetermined depth and a predetermined diameter are formed on the second layer.

Abstract: An optical ribbon fiber is disclosed and includes a plurality of optical fibers aligned in series, at least one strength member arranged at both side ends of the optical fibers or interposed between the optical members in order to reinforce a tensile strength of the optical ribbon fiber, and a ribbon coating layer coated onto outer surfaces of the optical fibers and the strength members so as to bond the optical fibers to the strength members.

Abstract: Disclosed is an optical fiber cable for an access network and includes: a ribbon optical fiber bundle formed by stacking a plurality of ribbon optical fibers, each of which comprises a plurality of optical fibers arranged in parallel and a jacket coated around the optical fibers; a plurality of tension members arranged in parallel along the longitudinal direction, so that they are brought into close contact with the ribbon optical fibers; and, an outer sheath extruded and coated around the ribbon optical fiber bundle and the tension members.